Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Guangzhou Darui Biotechnology

Request full access

In-vitro diagnostic products for precision medicine applications

Guangzhou, ChinaFounded 2003Biotech & Life Sciences

About Guangzhou Darui Biotechnology

In 2003, in the burgeoning metropolis of Guangzhou, a new entity was born not from a garage, but from the established prowess of a university. Guangzhou Darui Biotechnology emerged as a subsidiary of DAAN Gene Co., Ltd. of Sun Yat-sen University, starting its life with a clear mission: to innovate in molecular diagnostics. The company focused on developing high-tech platforms for critical health screenings, including prenatal, tumor, and infectious disease testing. This wasn't a story of a single product, but of building a comprehensive technological arsenal encompassing gene sequencing, mass spectrometry, and gene chip platforms to serve the clinical market. A pivotal moment arrived on July 9, 2015, when Darui Biotechnology was listed on the National Equities Exchange and Quotations, also known as the New Third Board in China. This step provided the resources to further its research and expand its footprint. The company continued to build, and under the leadership of figures like Chairman Dr. Ming Li, it forged key partnerships. A significant later-stage venture capital funding round of over $33 million in 2021 underscored investor confidence in its growth trajectory. Today, Darui stands as a key player in China's in-vitro diagnostic field, a testament to its strategic university origins and focused execution.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
18.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology, Medical Devices
Sector
Oncology, Genetics and genomics, Techbio, DT and LS, science-based
Technology
Deep Tech
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Apr 2022 $33M $132M Lanting Capital · CMB International · Platanus Ventures · Lilly Asia Ventures ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Guangzhou Darui Biotechnology website traffic

Latest recorded traffic for Guangzhou Darui Biotechnology is 1.3K monthly website visits, up 664.7% over the last three months.

Latest monthly visits1.3K 3-month web change+664.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Guangzhou Darui Biotechnology in the Guangzhou ecosystem

Live from Dealroom

The Guangzhou Darui Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Lanting Capital
  • CMB International
  • Platanus Ventures
  • Lilly Asia Ventures
  • Fengchuan Investment
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Guangzhou HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Guangzhou Darui Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Guangzhou Darui Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.